Message from Dr. Satoshi Ōmura about establishment of the COVID-19 emergency measures fund/获得诺贝尔医学・生理学奖的我校特别荣誉博士大村智先生，为“山梨大学新型冠状病毒感染紧急对策基金”项目的创立发来了声援信息

  On Thursday, May 7, 2020, we received a support message from Distinguished University Doctor Satoshi Ōmura, a graduate of our university. The message encouraged the establishment of the University of Yamanashi the COVID-19 Emergency Measures Fund.
  This fund was established in response to concerns that there may be a shortage of masks, medical gowns, diagnostic and medical equipment, as well as medical staff and supporting personnel as the spread of the COVID-19, and it will be used specifically to treat the disease.
  Dr. Satoshi Ōmura received the 2015 Nobel Prize in Physiology or Medicine for the development of the antiparasitic drug “Ivermectin” and for his contributions to the field of treatment of parasitic infections. The drug is also attracting worldwide attention for its potential to treat the COVID-19.
  The full message is as follows,
  The spread of the COVID-19 is tracing a course never before experienced, and is causing people to feel anxious. In this situation, the University of Yamanashi was one of the first to establish a system to accept patients with infectious diseases, and has been successful in doing so. The University of Yamanashi is improving its medical care by establishing specialized wards to prevent the spread of infectious diseases, while at the same time making various efforts to prevent the exhaustion of medical staff and the impact on general medical care. In order to succeed in these efforts, they have established a fund for the prevention of COVID-19, and are asking for the public’s support. As we work to prevent our own personal infections, let’s all work together to live with peace of mind, surrounded by the complete physical therapy facilities.
 Best regards!
    Satoshi Ōmura

　令和2年5月7日（星期四），我校毕业的大村智特别荣誉博士，为“山梨大学新型冠状病毒感染紧急对策基金”项目的创立发来了声援信息。
　随着新冠病毒的蔓延，对症治疗过程中所必需的口罩、防护服，以及医疗人员、辅助人员等均有可能出现短缺。该基金针对此而设立，专门用于此感染病症的治疗。
　大村博士因开发出抗寄生虫药“伊维菌素”，在治疗寄生虫感染症方面做出巨大贡献而获得2015年诺贝尔医学・生理学奖。同时，这种药物因对治疗新型冠状病毒的感染也有一定疗效，在世界上备受瞩目。
　消息全文如下。
　新型冠状病毒感染症的持续扩大，是人类目前为止都没有经历过的，这使人们陷入了深深的不安。
　在这样的情况下，山梨大学迅速调整体制，接收了感染患者，取得了相应的成绩。山梨大学为了防止感染扩大而设立了专门的就诊楼栋，一方面积极谋求诊疗技术的进一步提升，另一方面在防止医疗工作人员的过度疲劳、影响一般医疗等方面也做着各种各样的努力。为了促使这些努力的成功，设立了标题中提到的对策基金，积极呼吁社会上的人们对此进行支援。
　在为防御感染而努力的同时，积极完善身边的医疗设施，为了实现能够安心生活的日子，希望能和大家一起加油。
　请多关照。
　令和2年5月   大村 智